Abstract
I would like to emphasize three aspects of the clinical evaluation of a new drug intended for the treatment of chronic disease. Work on methyldigoxin will be quoted for illustration but the principles apply more widely.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beermann, B.: The gastrointestinal uptake of methyldigoxin 12 a- 3 H in man. Eur. J. clin. Pharmac. 5, 28–33 (1972).
Beermann, B., Hellström, K., and Rosén, A.: The absorption of orally administered 12a-3H digoxin in man. Clin. Sci. 43, 507–518 (1972).
Carbonin, P. U., Zecchi, P., Bellocci, F., Ruffa, S., and Loperfido, F.: Turnover metabolico della metildigossina-3H somministrata per via orale ed endovenosa nell’uomo normale. Abstract from the 32nd Congress of the Italian Society of Cardiology (1971).
Coburn, P., Kongola, G. M. W., and Mawer, G. E.: Comparison of medigoxin and digoxin in the control of atrial fibrillation. Br. J. clin. Pharmac. 8, 53–58 (1979).
Doering, W., König, E., Kronski, D., and Hall, D.: Bestimmung der Kenngrößen von ß-methyldigoxin mit Einschwemmkatheterverfahren und nicht invasiven Methoden. Dt. med. Wschr. 98, 2274–2280 (1973).
Doherty, J. E., Flanigan, W. J., Murphy, M. L., Bulloch, R. J., Dalrymple, J. W., Beard, O. W., and Perkins, W. H.: Tritiated digoxin. Enterohepatic circulation and excretion studies in human volunteers. Circulation 42, 867–873 (1970).
Hanel, G., Manninen, V., Melin, J., and Apajalahti, A.: Serum digoxin, concentrations with a new digoxin derivative, ß-methyldigoxin. Ann. clin. Res. 5, 87–90 (1973).
Hayward, R. P., Greenwood, H., and Hamer, J.: Comparison of digoxin and medigoxin in normal subjects. Brit. J. clin. Pharmac. 6, 81–86 (1978).
Huffman, D. H., Manion, C. V., and Azarnoff, D. L.: Absorption of digoxin from different oral preparations in normal subjects during steady state. Clin. Pharmac. Ther. 16, 310–317 (1974).
Johnson, B. F., and Bye, C. E.: Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration. British Heart Journal, 37, 203–208 (1975).
Johnson, B. F., Bye, C. E., Jones, G. E., and Sabey, G. A.: The pharmacokinetics of beta-methyldigoxin compared with digoxin tablets and capsules. Eur. J. clin. Pharmac. 10, 231–236 (1976).
König, E., and Ohly, A.: Quantitative Eigenschaften eines neuen Herzglycosids. Medsche. Klin., 65, 296–299 (1970).
Larbig, E., Scheler, F., Schmidt, H.-J, Betzien, G., and Kaufmann, B.: Untersuchungen zur enteralen Resorption von ß-Methyl-Digoxin. Klin. Wschr. 49, 604–607 (1971).
Limbourg, P., Just, H., Fiegel, P., Michaelis, J., and Rosellen, E.: Untersuchungen zur Resorption und zum Wirkungseintritt von ß-Methyl-Digoxin bei Patienten mit Vorhofflimmern. Arzneimittel-Forsch. 23, 60–63 (1973).
Rietbrock, N., Abshagen, U., Bergmann, K. V., and Rennekamp, H.: Disposition of ß-methyldigoxin in man. Eur. J. clin Pharmac. 9, 105–114 (1975).
Rietbrock, N., Guggenmos, J., Kuhlmann, J., and Hess, U.: Bioavailability and Pharmacokinetics of ß-Methyldigoxin after Multiple Oral and Intravenous Doses. Eur. J. clin. Pharmac. 9, 373–379 (1976).
Storz, H.: Zur Grundlage und Praxis einer Glykosidtherapie mit Digoxin. Ärztl. Wschr. 10, 796–802 (1955).
Storz, H.: Die quantitative wirksamkeit des herzglykosids ß-methyldigoxin. Medsche. Welt, Stuggt. 21, 2066–2070 (1970).
Strobach, H., Greeff, K., Horster, F. A., and Wildmeister, W.: Radioimmunologische Glykosidbestimmungen nach Gabe von Digoxin und seinen Digoxinderivaten beim Menschen. NaunynSchmiedebergs Arch. Pharmacol. 274, Suppl. R 113 (1972).
Wirth, K., Bodem, G., and Dengler, H. J.: Kinetik und Stoffwechsel von Digoxin und verwandten Herzglycosiden beim Menschen. Naunyn Schmiedebergs Arch. Pharmacol. 269, 427–428 (1971).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer Fachmedien Wiesbaden
About this chapter
Cite this chapter
Mawer, G.E. (1980). Cardiac glycosides in atrial fibrillation. In: Rietbrock, N., Woodcock, B.G., Neuhaus, G. (eds) Methods in Clinical Pharmacology. Methods in clinical pharmacology, vol 1. Vieweg+Teubner Verlag, Wiesbaden. https://doi.org/10.1007/978-3-663-14027-6_16
Download citation
DOI: https://doi.org/10.1007/978-3-663-14027-6_16
Publisher Name: Vieweg+Teubner Verlag, Wiesbaden
Print ISBN: 978-3-528-07902-4
Online ISBN: 978-3-663-14027-6
eBook Packages: Springer Book Archive